pharmaphorum

JANUARY 14, 2021

Not so China, and especially not so the lead five European countries – on average European pharmaceutical companies saw a loss of 30% of the interactive time they previously had with healthcare professionals in 2020. Whatever the challenges, the pharmaceutical industry enters 2021 with a new sense of purpose. Pharma pivots East.

Pharmaceutical Companies 71

Pharmaceutical Companies Pharmaceutical Companies Labelling 71

Pharmaceutical Technology

MARCH 6, 2023

Based on preclinical research for their impact on aging, well-known drugs like metformin and rapamycin are already being considered for off-label usage, due to their accepted safety profile and cost-effectiveness. Bellantuono worries that labeling aging as a disease indication could be “agist” and would have social implications.

FDA 145

FDA Labelling Pharmaceutical Companies Pharmaceutical Companies 145

Pharmaceutical Technology

DECEMBER 22, 2022

As pharmaceutical companies launch their products across European countries, the joint procedure is intended to reduce the duplication of submissions with different evidence requirements and procedural times required at a country level, and thus streamline workflows and reduce administrative burden.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Labelling 52

Pharmaceutical Technology

MARCH 16, 2023

Most drugs used here are prescribed off-label, and experts say pharmaceutical companies remain hesitant to conduct clinical trials studying gender-affirming care. One of the reasons why organisations, including pharma companies, do not enter this debate is because these drugs are used off label, says Horowicz.

Labelling 144

Labelling Pharmaceutical Companies Pharmaceutical Companies Communication 144